Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
885
datasets available to search
ShareScore release 0.9.0
Dataset results
885 results for “cyclophosphamide”
Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01729338. IPD Sharing: NO. Countries: 1. Publications: 0.
Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00971737. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients
ClinicalTrials.gov study NCT00358657. IPD Sharing: NO. Countries: 1. Publications: 0.
Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies
ClinicalTrials.gov study NCT02224599. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults
ClinicalTrials.gov study NCT01462253. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
ClinicalTrials.gov study NCT05468359. IPD Sharing: YES. Countries: 1. Publications: 0.
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00918723. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide
ClinicalTrials.gov study NCT01282216. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT00667615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High-Dose Cyclophosphamide for Steroid Refractory GVHD
ClinicalTrials.gov study NCT00492921. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis
ClinicalTrials.gov study NCT01860170. IPD Sharing: NO. Countries: 1. Publications: 0.
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previ
ClinicalTrials.gov study NCT00407888. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
ClinicalTrials.gov study NCT03023046. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
ClinicalTrials.gov study NCT03220022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00939653. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00711828. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma
ClinicalTrials.gov study NCT03328104. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility
ClinicalTrials.gov study NCT00591851. IPD Sharing: Not stated. Countries: 1. Publications: 0.
R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00809341. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
ClinicalTrials.gov study NCT00258180. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.